openPR Logo
Press release

Artificial Intelligence (AI) in Genomics Market Generated Opportunities, Future Scope 2024-2031 | Fabric Genomics, International Business Machines, MICROSOFT, NVIDIA, AI Therapeutics

05-22-2024 03:10 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Coherent Market Insights

Artificial Intelligence (AI) in Genomics Market Generated

Market Overview:

Artificial intelligence (AI) is transforming genomics by enabling researchers to quickly and accurately analyze huge amounts of genomic and medical data. AI tools are being used for genomic analysis, precision medicine, drug discovery, and more.

Market Dynamics:

The Artificial Intelligence (AI) in Genomics Market is driven by continued advancements in AI technologies such as machine learning and deep learning. Machine learning algorithms can discover patterns in large, complex genomic and healthcare datasets that are impossible to identify through manual methods. This has improved our ability to diagnose, treat, and prevent diseases. Additionally, rising investment in AI genomics startups is also fueling market growth. Deep learning models are being used to build correlations between genetic variants and health conditions, which can help deliver personalized care plans and precision medicine approaches.

Sample Copy of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/6127

Market Drivers for AI in Genomics

Increased Efficiency in Genome Analysis and Sequencing

Artificial intelligence and machine learning is enabling more efficient and accurate analysis of genome sequencing data at an unprecedented scale and speed. Advanced algorithms can identify patterns and insights hidden in vast amounts of genomic data that would be impossible for humans to detect. This is driving significant improvements in efficiency and accuracy for genomic research.

Personalized Medicine and Precision Healthcare

AI is allowing for more data-driven and personalized approaches to medicine. By analyzing a patient's entire genome and other relevant health data, AI and machine learning tools can help clinicians deliver truly personalized healthcare. This includes predicting disease risks, diagnosing illnesses, choosing the best treatment options, and monitoring health over time based on an individual's unique genetic profile and other factors. The promise of precision medicine is a major driver for applying AI within genomics.

Market Restrain for AI in Genomics

Regulatory Hurdles around Data Privacy and Ethics

While genome sequencing and AI can advance patient care, they also raise valid concerns around data privacy and the ethical use of personal genetic information. Strict regulations are still being developed around handling genomic and health data. Ensuring patient consent, data security, and transparency is paramount. Any perceived overreaches by industry could stall growth if they undermine public trust. Regulators and companies must work closely together to enable innovation while protecting individuals.

Some of the Top Players in Artificial Intelligence (AI) in Genomics Market:

Fabric Genomics, International Business Machines, MICROSOFT, NVIDIA, AI Therapeutics, Ares Genetics, Benevolent AI, Deep Genomics, DIPLOID and among others.

Market Segmentation:

By Delivery Mode: On-Premises, Cloud-based
By Functionality: Genome Sequencing, Gene Editing, and Others
By Application: Translational Precision Medicine, Clinical & Genomic Diagnostics and Others
By End User: Pharma & Biotech Companies, Public & Consumer Genomic Center and Others

To Purchase Report, Click Here @ https://www.coherentmarketinsights.com/insight/buy-now/6127

Market Opportunity for AI in Genomics

Drug Discovery and Precision Therapeutics

AI shows great potential to drive new discoveries in precision medicine by accelerating drug discovery, repurposing existing drugs, and improving clinical trial design. Genomic data combined with other data sources can help reveal new drug targets, biomarkers, and insights that shorten development timelines and improve success rates. This represents a major opportunity to apply AI for more targeted disease therapies.

Market Trend for AI in Genomics

Integration of Multi-omics Data

A notable trend is the growing integration of diverse types of biological data beyond just genomics. This includes things like proteomics, metabolomics, transcriptomics, and more. Much like how self-driving cars rely on integrating data from multiple sensors, combining these "multi-omics" datasets using AI promises more comprehensive portraits of health and disease. Slicing biological data from multiple angles will be necessary for realizing the full promise of precision healthcare.

Reasons to Purchase this Report:

👉Regional report analysis highlighting the consumption of products/services in a region also shows the factors that influence the market in each region.
👉Reports provide opportunities and threats faced by suppliers in the Artificial Intelligence (AI) in Genomics industry around the world.
👉The report shows regions and sectors with the fastest growth potential.
👉A competitive environment that includes market rankings of major companies, along with new product launches, partnerships, business expansions, and acquisitions.
👉The report provides an extensive corporate profile consisting of company overviews, company insights, product benchmarks, and SWOT analysis for key market participants.
👉This report provides the industry's current and future market outlook on the recent development, growth opportunities, drivers, challenges, and two regional constraints emerging in advanced regions.

Get Customized Report @ https://www.coherentmarketinsights.com/insight/request-customization/6127

Questions Answered by the Report:

(1) Which are the dominant players of the Artificial Intelligence (AI) in Genomics Market?
(2) What will be the size of the Artificial Intelligence (AI) in Genomics Market in the coming years?
(3) Which segment will lead the Artificial Intelligence (AI) in Genomics Market?
(4) How will the market development trends change in the next five years?
(5) What is the nature of the competitive landscape of the Artificial Intelligence (AI) in Genomics Market?
(6) What are the go-to strategies adopted in the Artificial Intelligence (AI) in Genomics Market?

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬:
Mr. Shah
Coherent Market Insights Pvt. Ltd,
📞Phone: U.S.: +1-206-701-6702
📞U.K.: +44-020-8133-4027
📞JAPAN: +81-50-5539-1737
📞INDIA: +91-848-285-0837
✉ Email: sales@coherentmarketinsights.com

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Artificial Intelligence (AI) in Genomics Market Generated Opportunities, Future Scope 2024-2031 | Fabric Genomics, International Business Machines, MICROSOFT, NVIDIA, AI Therapeutics here

News-ID: 3508464 • Views:

More Releases from Coherent Market Insights

Upper Limb Prosthetics Market Expected to Expand at a steady 2024-2031 with Future Trends, Key Insights and Business Strategies for Open Bionics, Coapt LLC, WillowWood Global LLC, Steeper Inc
Upper Limb Prosthetics Market Expected to Expand at a steady 2024-2031 with Futu …
Coherent Market Insights has released a statistical report titled "Upper Limb Prosthetics Market Recent Trends, In-depth Analysis, Size, and Forecast 2024-2031." This report offers a comprehensive overview of the competitive landscape, geographical segmentation, innovation, future developments, and a compilation of tables and data. The competitive landscape analysis provides detailed information about each vendor, encompassing company profiles, total revenue (financials), market potential, presence, market share, pricing, locations of production facilities, and
Cancer Biopsy Market Expected to Expand at a steady 2024-2031 with Huge Demand, Potential Growth, Business Prospect for QIAGEN, Illumina, Inc., Angle PLC, Myriad Genetics
Cancer Biopsy Market Expected to Expand at a steady 2024-2031 with Huge Demand, …
Coherent Market Insights has released a statistical report titled "Cancer Biopsy Market Recent Trends, In-depth Analysis, Size, and Forecast 2024-2031." This report offers a comprehensive overview of the competitive landscape, geographical segmentation, innovation, future developments, and a compilation of tables and data. The competitive landscape analysis provides detailed information about each vendor, encompassing company profiles, total revenue (financials), market potential, presence, market share, pricing, locations of production facilities, and the
Chiropractic Care Market Expected to Expand at a steady 2024-2031 with Future Growth, Business Prospects, Developments Factors | Align Chiropractic, City Chiropractic, Aarhus Chiropractic
Chiropractic Care Market Expected to Expand at a steady 2024-2031 with Future Gr …
Coherent Market Insights has released a statistical report titled "Chiropractic Care Market Recent Trends, In-depth Analysis, Size, and Forecast 2024-2031." This report offers a comprehensive overview of the competitive landscape, geographical segmentation, innovation, future developments, and a compilation of tables and data. The competitive landscape analysis provides detailed information about each vendor, encompassing company profiles, total revenue (financials), market potential, presence, market share, pricing, locations of production facilities, and the
Urokinase Market Expected to Expand at a steady 2024-2031 with Future Trends, Key Insights and Business Strategies for Jiangsu Aidea Pharmaceutical Co Ltd, Jiangxi Haoran Bio-Pharma Co
Urokinase Market Expected to Expand at a steady 2024-2031 with Future Trends, Ke …
Coherent Market Insights has released a statistical report titled "Urokinase Market Recent Trends, In-depth Analysis, Size, and Forecast 2024-2031." This report offers a comprehensive overview of the competitive landscape, geographical segmentation, innovation, future developments, and a compilation of tables and data. The competitive landscape analysis provides detailed information about each vendor, encompassing company profiles, total revenue (financials), market potential, presence, market share, pricing, locations of production facilities, and the introduction

All 5 Releases


More Releases for Genomic

Genomic Biomarkers Market 2022 | Detailed Report
The research reports on “Genomic Biomarkers Market” report gives detailed overview of factors that affect global business scope. Genomic Biomarkers Market report shows the latest market insights with upcoming trends and breakdowns of products and services. This report provides statistics on the market situation, size, regions and growth factors. An exclusive data offered in this report is collected by research and industry experts team. Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5334064 The
Global Cancer Genomic Testing Market Demand 2020-2025
GLOBAL INFO RESEARCHadded a new COVID-19 research report to its exhaustive repository. The research report, titled [Global and China Cancer Genomic Testing Market 2020 by Company, Type and Application, Forecast to 2025], presents an unbiased approach at understanding the market trends and dynamics. Analysts have studied the historical data pertaining to the market and compared it to the current market trends to paint an object picture of the market's trajectory.
Latest Survey on Genomic Medicine Market 2019 by Key Companies Overview-BioMed C …
The recently published report called “Global Genomic Medicine Market 2019” offers a brief overview of the Genomic Medicine market across the globe. The research report showcases innovative tool for evaluating the complete scenario of the Genomic Medicine market with its tactical decision making, opportunities and supporting strategic. Furthermore, the report also analyses the competitive analysis as well as changing trends which becomes most crucial in order to monitor the performance
Genomic Medicine Market Share and Growth 2019| BioMed Central, Cleveland Clinic, …
The report on the global Genomic Medicine market is comprehensively prepared with main focus on the competitive landscape, geographical growth, segmentation, and market dynamics, including drivers, restraints, and opportunities. It sheds light on key production, revenue, and consumption trends so that players could improve their sales and growth in the Global Genomic Medicine Market. It offers a detailed analysis of the competition and leading companies of the global Genomic Medicine
Cardiology Genomic Testing Market Impact Analysis By 2028
Heart disorders can be inherited and passed from parents to children via their genes. Cardiology genomic testing helps in detecting diseases such as aortopathy and congenital heart diseases. Also, it can be useful for family members who are at a risk of developing heart problems. Genetic disorders affect the development of blood vessels and lead to heart diseases. Identification of genetic causes can save lives. The technology used for cardiology
Emerging Growth of Global Genomic Medicine Market to 2019-2025| Center for Genom …
Researchmoz (RMOZ) added Most up-to-date research on "Global Genomic Medicine Market Size, Status and Forecast 2019-2025" to its huge collection of research reports. NHGRI defines genomic medicine as "an emerging medical discipline that involves using genomic information about an individual as part of their clinical care and the health outcomes and policy implications of that clinical use." Backed by government investments in precision medicine initiatives such as a multimillion dollar investment by